Research Article
Development of Biomarker Signatures Associated with Anoikis to Predict Prognosis in Endometrial Carcinoma Patients
Figure 8
Analysis of immunotherapy response of EC patients. (a) TIDE score in two groups. (b) CAF score in two groups. (c) MDSC score in two groups. (d) T-cell exclusion score in two groups. (e) T-cell dysfunction score in two groups.
(a) |
(b) |
(c) |
(d) |
(e) |